NCT02467270 2026-03-17
OPTIC
Takeda
Phase 2 Completed
Clinical Trials
953 trialsNCT06072833 2026-03-16
Characterizing and Addressing Financial Toxicity in AYAs With Cancer
Columbia University
Phase NA Completed
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT04055948 2026-03-09
Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients
Case Comprehensive Cancer Center
Phase NA Completed
NCT04332653 2026-03-09
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
Phase 1/2 Completed
NCT05148078 2026-03-02
Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT01602380 2026-02-27
FALCON
AstraZeneca
Phase 3 Completed
NCT01909453 2026-02-27
COLUMBUS
Pfizer
Phase 3 Completed
NCT03060096 2026-02-27
Telehealth
Wake Forest University Health Sciences
Phase NA Completed
NCT05358951 2026-02-27
Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)
Dana-Farber Cancer Institute
Phase NA Completed
NCT03400332 2026-02-24
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
Bristol-Myers Squibb
Phase 1/2 Completed
NCT04461509 2026-02-20
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
Phase 2 Completed
NCT06837090 2026-02-20
SPAINTRK
Grupo Espanol de Tumores Neuroendocrinos
Completed
NCT03388190 2026-02-13
METIMMOX
University Hospital, Akershus
Phase 2 Completed
NCT03993353 2026-02-12
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
Phase 2 Completed
NCT05499663 2026-02-06
POSTHOC
University of Maryland, Baltimore
Phase 1/2 Completed
NCT05746429 2026-02-04
Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer
St. Jude Children's Research Hospital
Phase NA Completed
NCT04414306 2026-02-02
Screen to Save 2: Rural Cancer Screening Educational Intervention
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT05061823 2026-02-02
Bintrafusp Alfa Program Rollover Study
EMD Serono
Phase 3 Completed
NCT04260529 2026-01-29
CICILIA
Cytovation AS
Phase 1/2 Completed
NCT02952248 2026-01-27
A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
Boehringer Ingelheim
Phase 1 Completed
NCT03156114 2026-01-26
This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.
Boehringer Ingelheim
Phase 1 Completed
NCT05905250 2026-01-16
mHealthAYA
George Washington University
Phase NA Completed
NCT03824158 2026-01-14
Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial
University of Pittsburgh
Phase NA Completed
NCT05041257 2026-01-09
PICCOLO
AbbVie
Phase 2 Completed
NCT04317742 2026-01-07
eHealth Insomnia Intervention for Adult Survivors of Childhood Cancer
St. Jude Children's Research Hospital
Phase NA Completed
NCT05054725 2026-01-06
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Phase 2 Completed
NCT05228470 2026-01-06
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Pfizer
Phase 2 Completed
NCT05678998 2026-01-06
WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma
Werewolf Therapeutics, Inc.
Phase 1 Completed
NCT00006436 2025-12-30
EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT06013176 2025-12-29
BEST-PRO
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT01695005 2025-12-26
A Study of LY3039478 in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT05887401 2025-12-24
Physical Activity and Healthy Eating Among Young Adult Cancer Survivors
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT03433898 2025-12-19
This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer
Boehringer Ingelheim
Phase EARLY_PHASE1 Completed
NCT01440465 2025-12-17
NAVI
Centre Francois Baclesse
Completed
NCT02275910 2025-12-16
Phase 1 Study of E7090 in Subjects With Solid Tumor
Eisai Inc.
Phase 1 Completed
NCT02860676 2025-12-15
Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
University of California, San Diego
Phase 1 Completed
NCT03473652 2025-12-15
APPAHOCA
Centre Francois Baclesse
Phase NA Completed
NCT06347731 2025-12-15
Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT04266041 2025-12-12
High-density EEG in Neurological Disorders
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT01743131 2025-12-11
Abatacept as GVHD Prophylaxis Phase 2
Boston Children's Hospital
Phase 2 Completed
NCT02699697 2025-12-11
Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis
Wake Forest University Health Sciences
Phase NA Completed
NCT04175639 2025-12-09
ICAN-NC
Duke University
Phase NA Completed
NCT03668223 2025-12-05
PRISM-AC
Dana-Farber Cancer Institute
Phase NA Completed
NCT05432232 2025-12-02
CAIN
HistoSonics, Inc.
Phase NA Completed
NCT05706610 2025-12-02
A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults With Cancer
Children's Hospital Medical Center, Cincinnati
Phase NA Completed
NCT05383170 2025-11-28
Catalyst
Cytovation AS
Phase 1/2 Completed
NCT03307785 2025-11-25
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042
Tesaro, Inc.
Phase 1 Completed
NCT05200572 2025-11-25
DLR Pilot
University of Rochester
Phase NA Completed
NCT02197234 2025-11-20
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC
AstraZeneca
Phase 1 Completed